NASDAQ: PASGPassage Bio Inc Stock Ownership - Who owns Passage Bio?
Insider buying vs selling
Have Passage Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kathleen Borthwick | CFO | 2026-01-08 | 2,062 | $18.44 | $38.02kSell |
| William Chou | PRESIDENT AND CEO | 2026-01-08 | 4,076 | $18.44 | $75.16kSell |
| Lynx1 Capital Management LP | 10% Owner | 2025-09-15 | 11,900 | $6.99 | $83.17kBuy |
| Lynx1 Capital Management LP | 10% Owner | 2025-09-12 | 19,783 | $6.99 | $138.30kBuy |
| Lynx1 Capital Management LP | 10% Owner | 2025-09-11 | 325 | $6.96 | $2.26kBuy |
| Lynx1 Capital Management LP | 10% Owner | 2025-07-24 | 66,423 | $5.71 | $379.47kBuy |
| Lynx1 Capital Management LP | 10% Owner | 2025-07-23 | 49,302 | $5.74 | $283.04kBuy |
| Lynx1 Capital Management LP | 10% Owner | 2025-07-22 | 13,123 | $5.44 | $71.34kBuy |
| Orbimed Advisors LLC | 10% Owner | 2025-06-26 | 213,257 | $0.33 | $70.37kSell |
| Orbimed Advisors LLC | 10% Owner | 2025-06-25 | 138,800 | $0.33 | $45.80kSell |
PASG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PASG insiders and whales buy or sell their stock.
PASG Shareholders
What type of owners hold Passage Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbimed Advisors LLC | 377.94% | 12,013,666 | $151.37M | Insider |
| Frazier Life Sciences IX LP | 157.59% | 5,009,219 | $63.12M | Insider |
| Patrick J. Heron | 157.59% | 5,009,219 | $63.12M | Insider |
| Versant Venture Capital VI LP | 156.03% | 4,959,769 | $62.49M | Insider |
| Thomas Woiwode | 156.03% | 4,959,769 | $62.49M | Insider |
| Liam Ratcliffe | 82.41% | 2,619,430 | $33.00M | Insider |
| Stephen P. Squinto | 21.03% | 668,575 | $8.42M | Insider |
| Tadataka Yamada | 20.64% | 656,149 | $8.27M | Insider |
| Lynx1 Capital Management LP | 19.62% | 623,704 | $7.86M | Insider |
| Lynx1 Capital Management LP | 19.62% | 623,704 | $7.86M | Institution |
PASG vs Biotech Stocks
Passage Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.